July 24, 2021

Volume XI, Number 205

Advertisement

July 23, 2021

Subscribe to Latest Legal News and Analysis

July 22, 2021

Subscribe to Latest Legal News and Analysis

July 21, 2021

Subscribe to Latest Legal News and Analysis

Leadership Changes at the Federal Trade Commission

Joseph Simons, Chairman of the Federal Trade Commission (“FTC”) since May 1, 2018, has announced that he would resign effective January 29, 2021. Following Chairman Simons out of the FTC are, among others, Bureau of Competition Director Ian Conner and Bureau of Competition Deputy Directors Gail Levine and Daniel Francis. These individuals played key roles in the FTC’s enforcement efforts in the health care industry.

In addition, Commissioner Rohit Chopra was recently nominated by President Biden to lead the Consumer Financial Protection Bureau (“CFPB”), and is also expected to soon leave the FTC. Commissioner Chopra, who brought a layman’s perspective to antitrust enforcement, has a history with the CFPB and would appear well suited to run that agency.

Finally, Commissioner Rebecca Slaughter, with the FTC since May of 2018, has been appointed Acting Chair of the FTC. Prior to joining the FTC, Commissioner Slaughter served as Chief Counsel for Senator Chuck Schumer. According to the FTC’s posted biography, Commissioner Slaughter is known for building “a consensus of progressive vision.” During her time at the FTC, Commissioner Slaughter has “[t]argeted merger retrospectives, corrective enforcement, and expansion of the Commission’s rule making authorities . . .”

President Biden will have the opportunity to fill the vacancies created by the pending departures of Commissioners Simons and Chopra. It is expected that the new appointees will continue to lead the FTC’s aggressive oversight of the health care industry.

©2021 Epstein Becker & Green, P.C. All rights reserved.National Law Review, Volume XI, Number 28
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

John Steren, Epstein Becker Law Firm, Health Care Litigation Attorney
Member

E. John Steren is a Member of the Firm in the Health Care & Life Sciences and Litigation & Business Disputes practices, in the Washington, DC, office of Epstein Becker Green. Mr. Steren devotes a significant portion of his practice to helping health care organizations manage the antitrust risks of joint ventures and other business arrangements. He also focuses his practice on other complex commercial and civil litigation matters.

202-861-1825
Patricia M. Wagner, Epstein becker green, health care, life sciences
Member

PATRICIA M. WAGNER is a Member of the Firm in the Health Care and Life Sciences and Litigation practices, in the firm's Washington, DC, office. In 2014, Ms. Wagner was selected to the Washington DC Super Lawyers list in the area of Health Care.

Ms. Wagner's experience includes the following:

Advising clients on a variety of matters related to federal and state antitrust issues 

Representing clients in antitrust matters in front of the Federal Trade Commission and the United States Department of...

202-861-4182
Advertisement
Advertisement